| Primary information |
|---|
| sequence ID | Seq_4479 |
| Peptide sequence | KVPQVSTPTLVEVSR |
| CancerPDF_ID | CancerPDF_ID348, CancerPDF_ID9541, CancerPDF_ID11879, |
| PMID | 19795908,21533267,26992070 |
| Protein Name | Serum albumin,Serum albumin,Serum albumin |
| UniprotKB Entry Name | ALBU_HUMAN,ALBU_HUMAN,ALBU_HUMAN |
| Fluid | Plasma,Serum,Serum |
| M/Z | 547.3126667,547.31,1638.9305 |
| Charge | 3,3,NA |
| Mass (in Da) | NA,NA,1639.940159 |
| fdr | NA,NA,NA |
| Profiling Technique | LC-MS,LC-MS,LC-MS |
| Peptide Identification technique | MALDI-TOF/TOF,LC/MS/MS,LC-MS/MS |
| Quantification Technique | LC-MRM (multiple reaction monitoring),Multiple Reaction Monitoring,NA |
| Labelled/Label Free | Labelled,Label Free,Label Free |
| FDR | less than 7%,1.49,FDR 1 % |
| CancerPDF_ID | CancerPDF_ID348, CancerPDF_ID9541, CancerPDF_ID11879, |
| p-Value | NA,NA,NA |
| Software | FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT,SEQUEST and Maxquant |
| Length | 15,15,15 |
| Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Lung adenocarcinoma,Melanoma |
| Database | NCBI refseq Protein Database,Swissprot Database (57.4),SwissProt Database |
| Modification | NA,NA,NA |
| Number of Patients | "42 normal, 26 patients",62 lung adenocarcinoma and 30 healthy control,8 cancer samples and 4 healthy samples |
| Regulation | NA,"Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal","Present in 8 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." |
| Validation | NA,MRM-based validation of 19 candidates,na |
| Sensitivity | NA,NA,NA |
| Specificity | NA,NA,NA |
| Accuracy | NA,NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | 489922
|